FSI SID&GP | State Institute of Drugs and Good Practices

FSI “SID & GP” and CDSCO, India signed a cooperation agreement. Read more

The importance of reference samples in the development of pharmaceutical industry was discussed during the meeting of the Healthcare Commission of the General Council of the UNITED RUSSIA Party Read more

The program of the IX All-Russian GMP Conference with international participation has been published Read more

Attendees of the ‘Ensuring Drug Security’ Forum discussed issues of public trust in the Russian pharmaceutical products Read more

GMP-conference

About institute

State Institute of Drugs and Good Practices

The Federal State Institution «State Institute of Drugs and Good Practices» (also known as FSI «SID & GP») is a subordinate agency of the Russian Ministry of Industry and Trade. The Institute was founded in 1973. For more than 40 years, the Institute has been a major research facility in the field of pharmacy.

In 2013, the FSI «SID & GP» received accreditation as an expert organization for licensing control of pharmaceutical manufacturers during inspections conducted by the Russian Ministry of Industry and Trade.

In 2015, FSI «SID & GP» was authorized to conduct GMP inspections of pharmaceutical products for human use produced outside of the Russian Federation, to issue compliance verifications of pharmaceutical manufacturers with the GMP requirements.

The Institute is Headed by Vladislav Shestakov.

2024 © News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution content is expressly prohibited without the prior written consent of Division for International Cooperation and External Communications FSI «SID and GP».